Back to Top Skip to main content

DTRA contributes to historic Ebola vaccine effort

Air Force Staff Sgt. Lee Nembhard, an aeromedical evacuation technician assigned to the 375th Aeromedical Evacuation Squadron from Scott Air Force Base, Illinois, straps a simulated Ebola patient to a litter during a Transport Isolation System training exercise at Joint Base Charleston, South Carolina. (U.S. Air Force photo by Senior Airman Megan Munoz) Air Force Staff Sgt. Lee Nembhard, an aeromedical evacuation technician assigned to the 375th Aeromedical Evacuation Squadron from Scott Air Force Base, Illinois, straps a simulated Ebola patient to a litter during a Transport Isolation System training exercise at Joint Base Charleston, South Carolina. (U.S. Air Force photo by Senior Airman Megan Munoz)

Recommended Content:

Immunization Healthcare | Immunizations | Global Emerging Infections Surveillance | Global Health Engagement | Global Health Engagement

FORT BELVOIR, Va. — The team of researchers and program managers at the Defense Threat Reduction Agency (DTRA) that has worked to counter the threat of the Ebola Virus Disease (EVD) welcomed the announcement of the U.S. Food and Drug Administration’s (FDA) approval of the vaccine, Ervebo ®, to the pharmaceutical company Merck & Co., Inc., December 19, 2019.

The approval of the vaccine represents the culmination of nearly two decades of efforts by a host of teams from across the public and private sectors such as DTRA and Merck, international partners in North America, Europe and Africa, and non-governmental and international organizations. The World Health Organization (WHO) describes EVD as a rare but severe hemorrhagic fever. EVD has killed thousands over the course of outbreaks, primarily in sub-Saharan Africa, since it first appeared in the 1970s.

DTRA, a Department of Defense combat support agency that identifies and combats biological threats as part of its mission to counter weapons of mass destruction (WMD), began its work on the vaccine in 2014 during an especially deadly outbreak in West Africa. The outbreak made clear the danger EVD posed to U.S. national security interests abroad, as well as to the U.S. domestic population in the event of a pandemic. To counter the threat, DTRA quickly initiated a strategy to get a vaccine approved. The combat support agency coordinated a series of investment efforts and partnerships to deliver a baseline platform for a viable vaccine candidate to mitigate the spread of the deadly disease.

“DTRA’s agile contracting, and well-placed contacts throughout government, academia, and industry allowed DTRA to form partnerships and guide development of this vaccine from the early stages of development, through crucial preclinical, and critical phase 1 clinical safety trials to the actual phase 2 clinical efficacy trial that demonstrated effectiveness of this vaccine during the outbreak,” said L. Revell Phillips Ph.D., a member of DTRA’s research and development team.

DTRA’s pioneering approach started with a contract to BioProtection Systems, a small biotech company. DTRA and BioProtection Systems partnered with Public Health Agency Canada, who began developing the vaccine in 2001, to accelerate its development. With these three teams working together, the vaccine progressed to a series of nonclinical and clinical studies conducted at the U.S. Army Medical Research Institute of Infectious Disease (USAMRIID) and Walter Reed Army Institute of Research (WRAIR) defense laboratories.

As the effort evolved, DTRA leveraged its USAMRIID partner’s research capacity, resulting in international partnering agreements with the WHO. DTRA also coordinated with teams across the U.S. government as development of the vaccine progressed. The efforts of this research and development consortium produced viable data that would be transitioned to next-level partners.

“We exercised our ability to develop partnerships for a relevant need, which was critical in transitioning medical countermeasures to our advanced developers at the speed of relevancy,” said Army Maj. Jeffrey Froude, DTRA’s program manager for the EVD Vaccine.

Froude explained that DTRA bolstered its research and development investments through two key U.S. governmental partners. First, DTRA worked closely with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, for advanced trials and manufacturing activities. Second, DTRA teamed with the DoD’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) for the task of immunoassay development. For that development effort, JPEO-CBRND’s, office of the Joint Program Manager for CBRN Medical took the lead.

Following several years of coordinated research and development efforts by the coalition of partners, the promising vaccine candidate transitioned to next-level partners BARDA and Merck for more advanced human clinical trials and product manufacturing of the EVD vaccine.

“This vaccine’s rapid progress is a testament to the power of partnerships among government agencies and with the private sector,” said BARDA director Rick Bright.

Next-level partner BARDA and Merck, served as the transition point to conduct more advanced human clinical trials and product manufacturing on the Ebola vaccine with the Joint Program Executive office (JPEO) providing a testing capability that allowed Merck to test human and non-human primate samples. The Joint Project Manager for Chemical, Biological, Radiological and Nuclear Medical (JPM-CBRN), Army Col. Ryan Eckmeier, stated that this “interagency partnership from the beginning was critical to advancing this vaccine product.”

Merck’s expertise with licensing and manufacturing was instrumental in advancing the vaccine. The pharmaceutical giant partnered with the WHO, United Nations International Children's Emergency Fund, and Gavi Vaccine Alliance, among others, to strategize on how to best implement future public health preparedness and response efforts against EVD.

“We share in this achievement, and thank you all personally for your amazing support over the last five years,” said Beth-Ann G. Coller, executive director of Merck’s vaccine team in a note to the DTRA team. “This has truly been a journey and one that we are proud to have shared with our colleagues in DoD. Without the early and continued support of DTRA we would not be here today.”

DTRA continues to leverage its successful partnerships as the agency works to develop future countermeasures. DTRA and BARDA have active partnering agreements to develop vaccine and therapeutic medical countermeasures to address a diverse range of viral and bacterial infectious disease threats. Efforts will use a similar model to the one that supported development and approval of the EVD vaccine.

“As DTRA moves forward to new challenges, we will leverage continued utilization of the Ebola vaccine model, using a diverse range of ways that we can work with our academic, international, interagency and industrial partners through grants, contracts and other transaction authorities,” said Froude. “We have a proven paradigm on how to efficiently advance medical countermeasures working with our U.S. government partners in these endeavors.”

Disclaimer: Re-published content may be edited for length and clarity. Read original post.

You also may be interested in...

World AIDS Day puts spotlight on landmark DoD study

Article
12/2/2019
Dr. John Mascola, director of the National Institutes of Health Vaccine Research Center, discusses HIV vaccine progress at the Walter Reed Army Institute of Research, Nov. 26, during a World AIDS Day commemoration.  (U.S. Army photo)

Vaccine study shows infection risk lowered by 31 percent, offering hope for future

Recommended Content:

Immunization Healthcare | Research and Innovation | Global Health Engagement

CDC Yellow Book

Publication
11/21/2019

CDC Health Information for International Travel 2020

Recommended Content:

Immunization Healthcare

Preventing seasonal influenza

Article
11/13/2019
Air Force Staff Sgt. Jaqueline Mbugua and members of the Massachusetts Air National Guard’s 102nd Medical Group traveled to the Roxy Theater on Joint Base Cape Cod to provide flu shots to Airmen Nov. 2, 2019. (U.S. Air Force photo by Tech. Sgt. Thomas Swanson).

The best way to prevent the flu is to get vaccinated every year

Recommended Content:

Health Readiness | Immunization Healthcare | Immunizations

USNS Comfort strengthens partnership with Jamaica

Article
11/7/2019
Navy Cmdr. Sara Naczas, a nurse assigned to the hospital ship USNS Comfort, helps a boy roll his yo-yo at a temporary medical treatment site in Kingston, Jamaica. Comfort is working with health and government partners in Central America, South America, and the Caribbean to provide care on the ship and at a temporary medical treatment site, helping to relieve pressure on national medical systems, including those strained by an increase in cross-border migrants. (U.S. Navy Photo by Mass Communication Specialist 3rd Class Maria G. Llanos)

This marks the Comfort’s third visit to Jamaica

Recommended Content:

Global Health Engagement | Global Health Engagement

Honduran MEDRETEs provide invaluable surgical, training opportunities

Article
10/30/2019
Air Force Maj. Julia Nuelle, chief of Orthopaedic Hand and Microvascular Surgery at Brooke Army Medical Center, poses for a photo with a pediatric patient and her mother during a Medical Readiness Exercise in Tegucigalpa, Honduras. The team finished their mission by visiting their patients and delivering toys and coloring books to the hospital's pediatric ward. (Courtesy photo by Army Lt. Col. Lori Tapley)

MEDRETEs play a critical role in the training and readiness of military medical personnel

Recommended Content:

Global Health Engagement | Global Health Engagement

Comfort strengthens partnership following successful medical mission

Article
10/21/2019
Navy Naval Aircrewman (Helicopter) 2nd Class Benjamin Lazarus flies in an MH-60S Seahawk assigned to the “Dragon Whales” of Helicopter Sea Combat Squadron 28, as it transports supplies from the hospital ship USNS Comfort for a temporary medical treatment site in Basseterre, St. Kitts and Nevis. (U.S. Navy photo by Mass Communication Specialist 2nd Class Morgan K. Nall)

More than 800 medical professionals provided care for 3,677 patients

Recommended Content:

Global Health Engagement | Global Health Engagement

Army distributes 1.5 million flu vaccines

Article
10/10/2019
Navy Hospital Corpsman 2nd Class Alexander Wrigel (right), a medic assigned to Task Group 68.6, forward deployed to Camp Lemonnier, administers a flu shot to Navy Lt. Cmdr. Hector Ubinas. (U.S. Navy photo by Mass Communication Specialist 1st Class Joe Rullo)

Five to twenty percent of people in the U.S. are affected by the flu each season

Recommended Content:

Immunization Healthcare | Immunizations | Medical Logistics

Measles Myths: The Measles Can Be Life-Threatening

Video
9/30/2019
Measles Myths: The Measles Can Be Life-Threatening

Measles can be life-threatening, especially for children and among people who have a compromised immune system.

Recommended Content:

Preventive Health | Children's Health | Immunizations | Immunization Healthcare | Vaccine-Preventable Diseases | Measles-Mumps-Rubella

Comfort strengthens partnership with Grenada

Article
9/27/2019
Surgical staff transports a woman into the post-anesthesia care unit following her surgery aboard the hospital ship USNS Comfort as the ship is anchored off the coast of St. George's, Grenada. Comfort is working with health and government partners in Central America, South America, and the Caribbean to provide care on the ship and at land-based medical sites, helping to relieve pressure on national healthcare systems, including those strained by an increase in cross-border migrants. (U.S. Navy photo by Mass Communication Specialist 2nd Class Morgan K. Nall)

This marks the first visit to Grenada and the seventh to the region since 2007

Recommended Content:

Global Health Engagement | Global Health Engagement

Autumn ushers in season of falling under the weather with flu

Article
9/26/2019
A bronze bench and statue near the America Building at Walter Reed National Military Medical Center in Bethesda, Maryland, memorializes military dependent Trevor Lin. The 7-year-old's death in the fall of 2009 was attributed to influenza.  (Photo courtesy of Walter Reed-Bethesda)

Health care experts: Everyone 6 months and older should get vaccine

Recommended Content:

Immunization Healthcare | Immunizations

DoD, HHS implement Executive Order to modernize flu vaccines

Article
9/25/2019
Health care experts recommend that everyone 6 months and older – including the elderly, chronically ill people, and expectant mothers – receive the flu vaccine as soon as it becomes available. (DoD photo)

New task force aims to increase efficiency, effectiveness

Recommended Content:

Immunization Healthcare | Immunizations

Measles Myths: Hand Washing Alone Won't Prevent Measles

Video
9/23/2019
Measles Myths: Hand Washing Alone Won't Prevent Measles

Hand washing alone will not prevent the spread of measles. Dr. Margaret Ryan, preventive medicine physician, debunks some myths about vaccinations.

Recommended Content:

Preventive Health | Children's Health | Immunizations | Immunization Healthcare | Vaccine-Preventable Diseases | Measles-Mumps-Rubella

Measles Myths: Vaccines Are Safe

Video
9/17/2019
Measles Myths: Vaccines Are Safe

Vaccine components have been rigorously tested for safety. Dr. Margaret Ryan, preventive medicine physician, debunks some myths about vaccinations.

Recommended Content:

Preventive Health | Children's Health | Immunizations | Immunization Healthcare | Vaccine-Preventable Diseases | Measles-Mumps-Rubella

U.S. builds bonds in Papua New Guinea

Article
9/17/2019
Navy Lt. Austin Stokes, (right), and Air Force Maj. Nicole Smith (center), both dentists, talk to a patient at the Pacific Angel 19-4 health outreach site in Lae, Papua New Guinea. The health outreach site is comprised of five clinics including primary care, optometry, dental, physical therapy and pharmacy. (U.S. Air Force photo by Staff Sgt. Jerilyn Quintanilla)

This is the second Pacific Angel exercise conducted in Papua New Guinea

Recommended Content:

Global Health Engagement | Humanitarian Assistance and Disaster Relief | Global Health Engagement

Measles Myths: Vaccines Do Not Cause Autism

Video
9/12/2019
Measles Myths: Vaccines Do Not Cause Autism

Vaccines that prevent measles do not cause autism. Dr. Margaret Ryan, preventive medicine physician, debunks some myths about vaccinations.

Recommended Content:

Preventive Health | Children's Health | Immunizations | Immunization Healthcare | Vaccine-Preventable Diseases | Measles-Mumps-Rubella | Autism Care Demonstration
<< < 1 2 3 4 5  ... > >> 
Showing results 31 - 45 Page 3 of 12

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.